A detailed history of Ci Investments Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Ci Investments Inc. holds 55 shares of HAE stock, worth $4,007. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55
Holding current value
$4,007
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$72.45 - $91.58 $3,984 - $5,036
55 New
55 $4,000
Q1 2024

May 13, 2024

BUY
$71.24 - $85.35 $8,121 - $9,729
114 New
114 $10,000
Q4 2019

Feb 11, 2020

SELL
$114.37 - $129.46 $464,570 - $525,866
-4,062 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$117.16 - $138.52 $475,903 - $562,668
4,062 New
4,062 $512,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.74B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Ci Investments Inc. Portfolio

Follow Ci Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.